These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25211043)

  • 1. Towards polymetallic lanthanide complexes as dual contrast agents for magnetic resonance and optical imaging.
    Debroye E; Parac-Vogt TN
    Chem Soc Rev; 2014 Dec; 43(23):8178-92. PubMed ID: 25211043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoquinoline-based lanthanide complexes: bright NIR optical probes and efficient MRI agents.
    Caillé F; Bonnet CS; Buron F; Villette S; Helm L; Petoud S; Suzenet F; Tóth E
    Inorg Chem; 2012 Feb; 51(4):2522-32. PubMed ID: 22233349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A self-assembled complex with a titanium(IV) catecholate core as a potential bimodal contrast agent.
    Dehaen G; Eliseeva SV; Kimpe K; Laurent S; Vander Elst L; Muller RN; Dehaen W; Binnemans K; Parac-Vogt TN
    Chemistry; 2012 Jan; 18(1):293-302. PubMed ID: 22139970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lanthanide(III) complexes that contain a self-immolative arm: potential enzyme responsive contrast agents for magnetic resonance imaging.
    Chauvin T; Torres S; Rosseto R; Kotek J; Badet B; Durand P; Tóth E
    Chemistry; 2012 Jan; 18(5):1408-18. PubMed ID: 22213022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lanthanides in magnetic resonance imaging.
    Bottrill M; Kwok L; Long NJ
    Chem Soc Rev; 2006 Jun; 35(6):557-71. PubMed ID: 16729149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lanthanide complexes for magnetic resonance and optical molecular imaging.
    Laurent S; Vander Elst L; Muller RN
    Q J Nucl Med Mol Imaging; 2009 Dec; 53(6):586-603. PubMed ID: 20016451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gadolinium(III) complexes as MRI contrast agents: ligand design and properties of the complexes.
    Hermann P; Kotek J; Kubícek V; Lukes I
    Dalton Trans; 2008 Jun; (23):3027-47. PubMed ID: 18521444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.
    Aime S; Castelli DD; Crich SG; Gianolio E; Terreno E
    Acc Chem Res; 2009 Jul; 42(7):822-31. PubMed ID: 19534516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
    Caravan P
    Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Water soluble, cyclometalated Pt(ii)-Ln(iii) conjugates towards novel bimodal imaging agents.
    Stacey OJ; Amoroso AJ; Platts JA; Horton PN; Coles SJ; Lloyd D; Williams CF; Hayes AJ; Dunsford JJ; Pope SJ
    Chem Commun (Camb); 2015 Aug; 51(61):12305-8. PubMed ID: 26137914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ParaCEST MRI contrast agents capable of derivatization via"click" chemistry.
    Milne M; Chicas K; Li A; Bartha R; Hudson RH
    Org Biomol Chem; 2012 Jan; 10(2):287-92. PubMed ID: 22069041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefiting from the unique properties of lanthanide ions.
    Bünzli JC
    Acc Chem Res; 2006 Jan; 39(1):53-61. PubMed ID: 16411740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of calcium-induced aggregation on the sensitivity of aminobis(methylenephosphonate)-containing potential MRI contrast agents.
    Henig J; Mamedov I; Fouskova P; Tóth É; Logothetis NK; Angelovski G; Mayer HA
    Inorg Chem; 2011 Jul; 50(14):6472-81. PubMed ID: 21671565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lanthanide-containing polycations for monitoring polyplex dynamics via lanthanide resonance energy transfer.
    Kelkar SS; Xue L; Turner SR; Reineke TM
    Biomacromolecules; 2014 May; 15(5):1612-24. PubMed ID: 24611467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyridine-based lanthanide complexes combining MRI and NIR luminescence activities.
    Bonnet CS; Buron F; Caillé F; Shade CM; Drahoš B; Pellegatti L; Zhang J; Villette S; Helm L; Pichon C; Suzenet F; Petoud S; Tóth É
    Chemistry; 2012 Jan; 18(5):1419-31. PubMed ID: 22213187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel polycarboxylated EDTA-type cyclodextrins as ligands for lanthanide binding: study of their luminescence, relaxivity properties of Gd(iii) complexes, and PM3 theoretical calculations.
    Maffeo D; Lampropoulou M; Fardis M; Lazarou YG; Mavridis IM; Mavridou DA; Urso E; Pratsinis H; Kletsas D; Yannakopoulou K
    Org Biomol Chem; 2010 Apr; 8(8):1910-21. PubMed ID: 20449498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging.
    Werner EJ; Datta A; Jocher CJ; Raymond KN
    Angew Chem Int Ed Engl; 2008; 47(45):8568-80. PubMed ID: 18825758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High relaxivity and stability of a hydroxyquinolinate-based tripodal monoaquagadolinium complex for use as a bimodal MRI/optical imaging agent.
    Tallec G; Fries PH; Imbert D; Mazzanti M
    Inorg Chem; 2011 Sep; 50(17):7943-5. PubMed ID: 21830834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De Novo Designed Imaging Agents Based on Lanthanide Peptides Complexes.
    Peacock AF
    Methods Enzymol; 2016; 580():557-80. PubMed ID: 27586349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From spherical to osmotically shrunken paramagnetic liposomes: an improved generation of LIPOCEST MRI agents with highly shifted water protons.
    Terreno E; Cabella C; Carrera C; Delli Castelli D; Mazzon R; Rollet S; Stancanello J; Visigalli M; Aime S
    Angew Chem Int Ed Engl; 2007; 46(6):966-8. PubMed ID: 17167807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.